Cell therapy is a kind of treatment in which intact, living cells are introduced into a patient’s body to replace, repair, reconstruct, or supplement damaged cells or tissues. It involves harvesting cells from autologous or allogenic sources, followed by in vitro cultivation of these cells, and then injection of cells back into the patient’s body. There are two main types of cell therapy: immune cell therapy and stem cell transplant.
Immune cell therapy (immunotherapy)
Immune cell refers to cell in the immune system that is responsible for attacking foreign pathogens and removing tumors or damaged cells in the body. Current immune cell therapy types involve natural killer cell (NK cell), cytokine-induced killer cell (CIK cell) and dendritic cell (DC). The National Institutes of Health (NIH) in the U.S. has also included immunotherapy as the fourth cancer treatment method, where the other three are surgery, radiation therapy and chemotherapy.
Stem cell transplant
Stem cell refers to a potent cell that is capable of differentiating into other types of more specialized cells. Based on its potency and function, stem cells can be separated into embryonic stem cell (ESC), mesenchymal stem cells (MSC) and hematopoietic stem cell (HSC). Since stem cells can be differentiated and developed into various tissues and organs in our body such as blood, brain and bone, it is widely applicable.
MBC is dedicated to the development of new medical techniques and new drug, committed to find innovative solutions for cancer treatment. We received Bio Taipei Awards for Immune Killer Cell Therapies in 2006 and has restarted our cell therapy project (Magicell) in 2016 – our R&D team combines advanced scientific technology with innovation to develop state-of-the-art natural killer cell therapy technology. Since 2017, we have been planning on building a cell manipulation laboratory of international standards. We have also embarked on research about immune cell therapy other than NK cell, and mesenchymal stem cells (MSC) cultivation technology, hoping to provide our patients with new treatment choices.